{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:09:24Z","timestamp":1759010964680},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11596-016-1643-2","type":"journal-article","created":{"date-parts":[[2016,10,17]],"date-time":"2016-10-17T07:41:52Z","timestamp":1476690112000},"page":"667-676","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Splenectomy suppresses growth and metastasis of hepatocellular carcinoma through decreasing myeloid-derived suppressor cells in vivo"],"prefix":"10.1007","volume":"36","author":[{"given":"Xin","family":"Long","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-fang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan-guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"issue":"9822","key":"1643_CR1","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet, 2012,379(9822):1245\u20131255","journal-title":"Lancet"},{"issue":"24","key":"1643_CR2","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMoa1300297","volume":"368","author":"KJ Yong","year":"2013","unstructured":"Yong KJ, Gao C, Lim JS, et al. Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med, 2013,368(24):2266\u20132276","journal-title":"N Engl J Med"},{"key":"1643_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4137\/CMO.S9926","volume":"8","author":"A Flores","year":"2014","unstructured":"Flores A, Marrero JA. Emerging trends in hepatocellular carcinoma: focus on diagnosis and therapeutics. Clin Med Insights Oncol, 2014,8:71\u201376","journal-title":"Clin Med Insights Oncol"},{"issue":"8","key":"1643_CR4","first-page":"388","volume":"33","author":"KR Wei","year":"2014","unstructured":"Wei KR, Yu X, Zheng RS, et al. Incidence and mortality of liver cancer in China, 2010. Chin J Cancer, 2014,33(8):388\u2013394","journal-title":"Chin J Cancer"},{"key":"1643_CR5","doi-asserted-by":"crossref","unstructured":"Wei S, Hao X, Zhan D, et al. Are surgical indications of Barcelona Clinic Liver Cancer staging classification justified? J Huazhong Univ Sci Technolog Med Sci, 2011,31(5):637\u2013641","DOI":"10.1007\/s11596-011-0574-1"},{"issue":"3","key":"1643_CR6","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/carcin\/bgr319","volume":"33","author":"S Wei","year":"2012","unstructured":"Wei S, Xiong M, Zhan DQ, et al. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway. Carcinogenesis, 2012,33(3):538\u2013547","journal-title":"Carcinogenesis"},{"issue":"8","key":"1643_CR7","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/modpathol.3800141","volume":"17","author":"AI Colovai","year":"2004","unstructured":"Colovai AI, Giatzikis C, Ho EK, et al. Flow cytometric analysis of normal and reactive spleen. Mod Pathol, 2004,17(8):918\u2013927","journal-title":"Mod Pathol"},{"issue":"8","key":"1643_CR8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE. Kraal G. Structure and function of the spleen. Nat Rev Immunol, 2005,5(8):606\u2013616","journal-title":"Nat Rev Immunol"},{"issue":"10","key":"1643_CR9","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/sj.leu.2404927","volume":"21","author":"FJ Dieguez-Acuna","year":"2007","unstructured":"Dieguez-Acuna FJ, Gygi SP, Davis M, et al. Splenectomy: a new treatment option for ALL tumors expressing Hox-11 and a means to test the stem cell hypothesis of cancer in humans. Leukemia, 2007,21(10):2192\u20132194","journal-title":"Leukemia"},{"issue":"7","key":"1643_CR10","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1073\/pnas.1113744109","volume":"109","author":"V Cortez-Retamozo","year":"2012","unstructured":"Cortez-Retamozo, V, Etzrodt M, Newton A, et al. Origins of tumor-associated macrophages and neutrophils. Proc Natl Acad Sci USA, 2012,109(7):2491\u20132496","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"1643_CR11","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.celrep.2012.08.006","volume":"2","author":"S Ugel","year":"2012","unstructured":"Ugel S, Peranzoni E, Desantis G, et al. Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep, 2012,2(3):628\u2013639","journal-title":"Cell Rep"},{"issue":"7","key":"1643_CR12","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00262-014-1546-7","volume":"63","author":"S Xia","year":"2014","unstructured":"Xia S, Li X, Cheng L, et al. Chronic intake of high fish oil diet induces myeloid-derived suppressor cells to promote tumor growth. Cancer Immunol Immunother, 2014,63(7):663\u2013673","journal-title":"Cancer Immunol Immunother"},{"issue":"11","key":"1643_CR13","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1182\/blood-2004-08-3210","volume":"105","author":"Y Shaked","year":"2005","unstructured":"Shaked Y, Cervi D, Neuman M, et al. The splenic microenvironment is a source of proangiogenesis\/inflammatory mediators accelerating the expansion of murine erythroleukemic cells. Blood, 2005,105(11):4500\u20134507","journal-title":"Blood"},{"key":"1643_CR14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-4682-3-23","volume":"3","author":"RT Prehn","year":"2006","unstructured":"Prehn RT. The paradoxical effects of splenectomy on tumor growth. Theor Biol Med Model, 2006,3:23","journal-title":"Theor Biol Med Model"},{"issue":"5","key":"1643_CR15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000095415","volume":"38","author":"K Sonoda","year":"2006","unstructured":"Sonoda K, Izumi K, Matsui Y, et al. Decreased growth rate of lung metastatic lesions after splenectomy in mice. Eur Surg Res, 2006,38(5):469\u2013475","journal-title":"Eur Surg Res"},{"issue":"5","key":"1643_CR16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011,144(5):646\u2013674","journal-title":"Cell"},{"issue":"3","key":"1643_CR17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 2009,9(3):162\u2013174","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1643_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cyto.b.21206","volume":"88","author":"V Damuzzo","year":"2015","unstructured":"Damuzzo V, Pinton L, Desantis G, et al. Complexity and challenges in defining myeloid-derived suppressor cells. Cytometry B Clin Cytom, 2015,88(2):77\u201391","journal-title":"Cytometry B Clin Cytom"},{"issue":"10","key":"1643_CR19","first-page":"3181","volume":"7","author":"N Chi","year":"2014","unstructured":"Chi N, Tan Z, Ma K, et al. Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and -6 in prostate cancer. Int J Clin Exp Med, 2014,7(10):3181\u20133192","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"1643_CR20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s11596-014-1264-6","volume":"34","author":"RJ Li","year":"2014","unstructured":"Li RJ, Liu L, Gao W, et al. Cyclooxygenase-2 blockade inhibits accumulation and function of myeloid-derived suppressor cells and restores T cell response after traumatic stress. J Huazhong Univ Sci Technolog Med Sci, 2014,34(2):234\u2013240","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"6","key":"1643_CR21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11596-013-1204-x","volume":"33","author":"XJ Zhu","year":"2013","unstructured":"Zhu XJ, Hu J, Sun L, et al. Amplification of functional myeloid-derived suppressor cells during stem cell mobilization induced by granulocyte colony-stimulationfactor. J Huazhong Univ Sci Technolog Med Sci, 2013,33(6):817\u2013821","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"11","key":"1643_CR22","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1002\/eji.201344335","volume":"44","author":"M Schmid","year":"2014","unstructured":"Schmid M, Zimara N, Wege AK, et al. Myeloid-derived suppressor cell functionality and interaction with Leishmania major parasites differ in C57BL\/6 and BALB\/c mice. Eur J Immunol, 2014,44(11):3295\u20133306","journal-title":"Eur J Immunol"},{"issue":"8","key":"1643_CR23","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","volume":"111","author":"K Movahedi","year":"2008","unstructured":"Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cellsuppressive activity. Blood, 2008,111(8):4233\u20134244","journal-title":"Blood"},{"issue":"8","key":"1643_CR24","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol, 2008,181(8):5791\u20135802","journal-title":"J Immunol"},{"key":"1643_CR25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-med-051013-052304","volume":"66","author":"T Condamine","year":"2015","unstructured":"Condamine T, Ramachandran I, Youn JI, et al. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annu Rev Med, 2015,66:97\u2013110","journal-title":"Annu Rev Med"},{"issue":"1","key":"1643_CR26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1189\/jlb.0311177","volume":"91","author":"JI Youn","year":"2012","unstructured":"Youn, JI, Collazo M, Shalova IN, et al. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol, 2012,91(1):167\u2013181","journal-title":"J Leukoc Biol"},{"issue":"8","key":"1643_CR27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoc","year":"2008","unstructured":"Murdoc, C, Muthana M, Coffelt SB, et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer, 2008,8(8):618\u2013631","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1643_CR28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.immuni.2014.10.009","volume":"41","author":"Y Skabytska","year":"2014","unstructured":"Skabytska Y, Wolbing F, Gunther C, et al. Cutaneous innate immune sensing of toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity, 2014,41(5):762\u2013775","journal-title":"Immunity"},{"issue":"1","key":"1643_CR29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00262-008-0523-4","volume":"58","author":"CM Diaz-Montero","year":"2009","unstructured":"Diaz-Montero CM, Salem ML, Nishimura MI, et al. Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol Immunother, 2009,58(1):49\u201359","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"1643_CR30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0254-6272(14)60095-9","volume":"34","author":"M Ren","year":"2014","unstructured":"Ren M, Ye L, Hao X, et al. Polysaccharides from Tricholoma matsutake and Lentinus edodes enhance 5-fluorouracil-mediated H22 cell growth inhibition. J Tradit Chin Med, 2014,34(3):309\u2013316","journal-title":"J Tradit Chin Med"},{"issue":"3","key":"1643_CR31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF02829497","volume":"23","author":"P Li","year":"2003","unstructured":"Li P, Feng Z, Zhang G, et al. Inhibitory effect of recombinant endostatin on angiogenesis and tumor growth of hepatoma. J Huazhong Univ Sci Technolog Med Sci, 2003,23(3):223\u2013226","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"1643_CR32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02830696","volume":"24","author":"L Qin","year":"2004","unstructured":"Qin L, Wang X, Duan Q, et al. Inhibitory effect of melatonin on the growth of H22 hepatocarcinoma cells by inducing apoptosis. J Huazhong Univ Sci Technolog Med Sci, 2004,24(1):19\u201321, 31","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"1","key":"1643_CR33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2008.11.035","volume":"277","author":"B Zhang","year":"2009","unstructured":"Zhang B, Halder SK, Zhang S, et al. Targeting transforming growth factor-beta signaling in liver metastasis of colon cancer. Cancer Lett, 2009,277(1):114\u2013120","journal-title":"Cancer Lett"},{"issue":"5","key":"1643_CR34","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.27273","volume":"60","author":"ZY Ding","year":"2014","unstructured":"Ding ZY, Jin, GN. Wang W, et al. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Hepatology, 2014,60(5):1620\u20131636","journal-title":"Hepatology"},{"issue":"5","key":"1643_CR35","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0022-4804(90)90011-P","volume":"48","author":"RE Schwarz","year":"1990","unstructured":"Schwarz RE, Hiserodt JC. Effects of splenectomy on the development of tumor-specific immunity. J Surg Res, 1990,48(5):448\u2013453","journal-title":"J Surg Res"},{"issue":"12","key":"1643_CR36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0022-3468(86)90021-7","volume":"21","author":"SP Brooks","year":"1986","unstructured":"Brooks SP, Rich GA, Huh YS, et al. Lymphoid cell populations in splenectomized and nonsplenectomized SJL\/J mice bearing Hodgkin\u2019s disease-like reticulum cell sarcoma. J Pediatr Surg, 1986,21(12):1114\u20131118","journal-title":"J Pediatr Surg"},{"issue":"9","key":"1643_CR37","first-page":"970","volume":"84","author":"H Miwa","year":"1983","unstructured":"Miwa H, Kojima K, Kobayashi T, et al. The tumor\u2014immunological significance of splenectomy for cancer therapy. Nihon Geka Gakkai Zasshi, 1983,84(9):970\u2013973","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"5","key":"1643_CR38","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00277-014-2276-9","volume":"94","author":"W Jing-Shi","year":"2015","unstructured":"Jing-Shi W, Yi-Ni W, Lin W, et al. Splenectomy as a treatment for adults with relapsed hemophagocytic lymphohistiocytosis of unknown cause. Ann Hematol, 2015,94(5):753\u2013760","journal-title":"Ann Hematol"},{"issue":"8","key":"1643_CR39","first-page":"605","volume":"85","author":"P Derlatka","year":"2014","unstructured":"Derlatka P, Grabowska-Derlatka L, Sienko J, et al. Splenectomy as a part of debulking surgery in patients with advanced ovarian cancer. Ginekol Pol, 2014,85(8):605\u2013608","journal-title":"Ginekol Pol"},{"issue":"1","key":"1643_CR40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10428194.2013.794269","volume":"55","author":"FP Santos","year":"2014","unstructured":"Santos FP, Tam CS, Kantarjian H, et al. Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. Leuk Lymphoma, 2014,55(1):121\u2013127","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1643_CR41","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/bjs.4776","volume":"92","author":"XP Chen","year":"2005","unstructured":"Chen XP, Wu ZD, Huang ZY, et al. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg, 2005,92(3):334\u2013339","journal-title":"Br J Surg"},{"key":"1643_CR42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/nyas.12469","volume":"1319","author":"S Solito","year":"2014","unstructured":"Solito S, Marigo I, Pinton L, et al. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann N Y Acad Sci, 2014,1319:47\u201365","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1643_CR43","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jhep.2013.04.033","volume":"59","author":"B Hochst","year":"2013","unstructured":"Hochst B, Schildberg FA, Sauerborn P, et al. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion. J Hepatol, 2013,59(3):528\u2013535","journal-title":"J Hepatol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-016-1643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-016-1643-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-016-1643-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T13:47:30Z","timestamp":1568468850000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-016-1643-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["1643"],"URL":"https:\/\/doi.org\/10.1007\/s11596-016-1643-2","relation":{},"ISSN":["1672-0733","1993-1352"],"issn-type":[{"value":"1672-0733","type":"print"},{"value":"1993-1352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}